4.7 Article

Accuracy of Carbapenem Nonsusceptibility for Identification of KPC-Possessing Enterobacteriaceae by Use of the Revised CLSI Breakpoints

期刊

JOURNAL OF CLINICAL MICROBIOLOGY
卷 49, 期 11, 页码 3931-3933

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.01176-11

关键词

-

资金

  1. Ortho-McNeil Johnson Johnson Co.
  2. Merck Co., Inc.
  3. Pfizer, Inc.

向作者/读者索取更多资源

Using the updated 2010 CLSI carbapenem breakpoints for the Enterobacteriaceae, nonsusceptibility to ertapenem and imipenem predicted the presence of bla(KPC) poorly, especially among Escherichia coli and Enterobacter species. In regions where KPC-producing bacteria are endemic, testing for nonsusceptibility to meropenem may provide improved accuracy in identifying these isolates.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据